Simulations Plus, Inc. announced that it has signed a research collaboration agreement with the FDA to determine the value of mechanistic absorption modeling (“MAM”) in developing predictive and robust in vitro-in vivo correlations (IVIVCs).
Naurex Inc. has announced that the FDA has granted Fast Track designation to the investigation of GLYX-13, the company's rapid-acting antidepressant in Phase 2 clinical development, as adjunctive therapy in major depressive disorder.
Dendreon Corporation today announced that it plans to make PROVENGE ® (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the United Kingdom.
AVCS-3SD is the only system on the market with fully automatic pressure and process flow control, as well as data acquisition, from 1.3x10-3 to 1.3x10+5 Pa (1x10-5 to 1000 Torr) with excellent accuracy.
The administration quietly issued a health law fix Thursday to help those states still trying to solve website problems that have eclipsed those experienced earlier by the federal HealthCare.gov site.
The Jan/Feb 2014 issue of Pharmaceutical Processing is our INTERPHEX 2014 Preview issue and features numerous exhibitor highlights and a guide to the educational conference program. In addition, we profile Xcelience, a clinical trial material contract manufacturer based in Tampa, FL.
A look at how pets with a rare illness can help design vaccines for humans.
In a petition to the FDA, anti-addiction groups call the newly-approved drug Zohydro the next Oxycontin and they are warning if it is released to pharmacies as scheduled, it will also lead to more addiction and drug-related deaths.
First the teenager survived a rare cancer. Then she wanted to study it, spurring a study that helped scientists find a weird gene flaw that might play a role in how the tumor strikes.
Democratic Sen. Barbara Boxer asked the federal Centers for Disease Control and Prevention on Thursday to initiate a formal investigation into what has caused polio-like paralysis in about 20 children in California over the past 18 months.
Bayer AG says its net profit jumped by almost a third last year to 3.19 billion euros ($4.35 billion) as sales hit a record high.
U.S. hospitals are coping better with ongoing shortages of hundreds of medications, but a new survey indicates that obtaining drugs from alternate sources is costing them a lot of money they can't spare.
Valeant Pharmaceuticals is seeing more clearly the merits of its acquisition last summer of eye care company Bausch and Lomb and remains on the hunt for another big acquisition this year.
A bill that started out as an effort to direct a state loan to a New Jersey pharmaceutical company and later morphed into an ambitious new state business loan program cleared the Wyoming Senate on Tuesday.
Delta T Systems, a leader in the manufacturing of water and oil temperature control equipment, has a new comprehensive website to better serve their customers. Enhanced features include a complete product selection tool, detailed quote form, printable documents, photo galleries, and much more.